Skip to main content
. 2021 Apr 22;13(5):605. doi: 10.3390/pharmaceutics13050605

Table 4.

GPC–RI values obtained from F01 and F02 formulations pre- and post-in vivo administration.

Formulation Test item Mn (kDa) Mw (kDa) Mp (kDa) Ð
F01 Formulation—t0 13.9 19.8 24.4 1.4
Explants—28 days 14.3 20.7 25.6 1.5
F02 Formulation—t0 7.3 10.3 10.0 1.4
Explants—28 days 7.5 10.4 9.8 1.4